SGMC studies cancer drug - WALB.com, Albany News, Weather, Sports

SGMC studies cancer drug

  • More WALB News10 HeadlinesMore News HeadlinesMore>>

  • Stores gear up for Tax Free Weekend

    Stores gear up for Tax Free Weekend

    Friday, August 1 2014 5:18 AM EDT2014-08-01 09:18:42 GMT
    Retail stores in South Georgia are gearing up for the tax free holiday weekend.More >>
    Retail stores in South Georgia are gearing up for the tax free holiday weekend.More >>
  • Shoppers fire up for tax free holiday

    Shoppers fire up for tax free holiday

    Friday, August 1 2014 4:12 AM EDT2014-08-01 08:12:21 GMT
    Calculators, spirals, backpacks...just a few essentials for back-to-school shopping and with a bonus of a tax free holiday, shoppers will be scrambling to snag the best deals. More >>
    Calculators, spirals, backpacks...just a few essentials for back-to-school shopping and with a bonus of a tax free holiday, shoppers will be scrambling to snag the best deals. More >>
  • Phoebe foundation receives donation for medical student housing

    Phoebe foundation receives donation for medical student housing

    Thursday, July 31 2014 11:25 PM EDT2014-08-01 03:25:30 GMT
    Lauren Ray, Phoebe Foundation Executive DirectorLauren Ray, Phoebe Foundation Executive Director
    A generous donation will help build a $5 million medical student housing facility on Phoebe Putney Memorial Hospital's campus.The Richard King Mellon Foundation donated $1 million to the Phoebe Foundation for the proposed 25-unit gated community. More >>
    A generous donation will help build a $5 million medical student housing facility on Phoebe Putney Memorial Hospital's campus.The Richard King Mellon Foundation donated $1 million to the Phoebe Foundation for the proposed 25-unit gated community. More >>

August 31, 2006

Valdosta - Studies indicate one out of six men run the risk of developing prostate cancer.

Doctors at South Georgia Medical Center in Valdosta are beginning a new study they hope will help these cancer patients.  The study is for men who have failed initial treatments after being diagnosed with prostate cancer and must move on to chemotherapy.

They hope the new drug, DN-101, combined with their regular treatments, will make the chemotherapy process easier to handle.  "They are adding an experimental drug which is basically an oral pill that has been shown to have better response rates with prostate cancer and actually allow men to tolerate kemotheropy better. So they had better outcomes and were able to tolerate treatments better," said Medical Oncologist, Dr. Eric Anderson.

The Pearlman Cancer Center at South Georgia Medical Center welcomes any men over the age of 18 who have prostate cancer and failed hormone treatments to participate in the study.

Feedback: news@walb.com?subject=ProstateResearch/Eakin